CD8A and graft versus host disease: These results suggested the ability of AMSC to inhibit proliferation of CD8+ T cells was significantly higher than that of BMSC, although AMSC and BMSC had the similar ability to inactivate of CD8+ T cells in xeno-GVHD mice.